THRD (Third Harmonic Bio Inc.) Company Cash Volume

Official company branding of Third Harmonic Bio (THRD)

The development dynamics of Third Harmonic Bio rely on trials of a KIT inhibitor against urticaria. Current cash reserves confirm the movement of liquid assets, where the status equals 0.27. Margin resilience is ensured by optimizing raw material supplies for research. Business efficiency is complemented by a virtual management structure, where top management loyalty is guaranteed by equity ownership in the company.

Third Harmonic Bio Inc. - THRD Company Cash Balance (period 04/28/2023 - 08/16/2025)

Analytical breakdowns for Third Harmonic Bio

- stock value and consensus price forecast:
Fundamental valuation:THRD thirdharmonicbio.com
Brand item of Third Harmonic Bio, Inc.

This indicator measures the dynamics of liquid assets, allowing for an assessment of management's financial discipline and the burn rate. Analyzing the accumulation trend helps investors determine the balance between the risk of funding shortages and capital efficiency. The dynamics of current cash reserves reflect the actual pace of operational funding. For Third Harmonic Bio (THRD), this is critical during the development of oral medications for urticaria. A sufficient cash cushion ensures the transition from injectable therapy to the mass market.

Competitors of Third Harmonic Bio

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|CLDX: Company Cash Balance|Company Cash Funds Aurinia Pharmaceuticals Inc. (AUPH)|Company Cash Funds BCRX (BioCryst Pharmaceuticals Inc)|Company Cash Volume VERA (Vera Corp)|Company Total Cash Amount DNTH (Dianthus Therapeutics)|PHVS - Company Cash Funds|ABCL: Company Cash Funds|TRML: Company Cash Volume|Company Cash on Hand Precigen, Inc.|Company Cash on Hand PHAR|Nektar Therapeutics - Company Total Cash Volume|Company Cash Funds Upstream Bio Corp (UPB)|Company Cash on Hand Zenas Biopharma ZBIO|Company Cash Funds Immunome Bio IMNM|GOSS: Company Cash and Cash Equivalents|kalvista.com - Company Cash Volume|SEPN (septerna.com) - Company Cash and Cash Equivalents|PVLA (Pieris Pharmaceuticals) - Company Cash on Hand|Savara - Company Cash Balance|RIGL (Rigel Corp) - Company Cash Volume|Company Cash Volume AnaptysBio Corp|Company Cash Funds astriatx.com (ATXS)|Company Cash on Hand enGene ENGN|Company Cash Funds RAPT Therapeutics, Inc. RAPT|JBIO - Company Cash on Hand|Aclaris Therapeutics Inc. - Company Cash Volume|KYTX - Company Cash Volume|TLSA (Tiziana Life Sciences PLC) - Company Cash on Hand|cabalettabio.com (CABA) - Company Cash Volume|Company Cash Funds Ventyx Biosciences|THTX (Theratechnologies) - Company Total Cash Amount|Company Cash on Hand AVTX (Avalo Therapeutics Inc.)|Company Cash Funds ELDN (Eledon)|Company Cash Volume AGEN (Agenus, Inc)|Company Liquid Assets climbbio.com (CLYM)|zurabio.com - Company Cash Volume|ATYR - Company Cash Volume|ADAG: Company Cash Volume|Ikena Oncology, Inc. (IMA) - Company Cash Volume|STTK (Shattuck Therapeutics) - Company Cash Volume|Company Cash Reserve equilliumbio.com EQ|Company Cash Volume CNTB|IMUX - Company Cash Reserve|Company Cash Funds Atara Biotherapeutics ATRA|Company Liquid Assets InflaRx N.V. (IFRX)|XFOR: Company Cash on Hand|adicetbio.com (ACET) - Company Cash on Hand|CELU: Company Cash Volume|Company Cash Reserve INmune Bio (INMB)|Company Cash Funds Barinthus Bio|Company Cash and Cash Equivalents KZR (Kezar Life Sciences, Inc)|Company Cash on Hand SABS (SAB Biotherapeutics Inc)|Akari Therapeutics - Company Cash and Cash Equivalents|Enlivex Therapeutics Ltd - Company Cash on Hand|Company Cash Balance QTTB|GOVX - Company Cash Funds|Company Cash Reserve Edesa|IBIO: Company Cash Volume|Company Cash Reserve Carisma Therapeutics Inc (CARM)|Company Cash Funds XTL Biopharmaceuticals, Ltd.|Company Cash Funds BOLT|Company Cash on Hand HCWB (HCW Biologics, Inc.)|Company Total Cash Amount APVO|AIM ImmunoTech - Company Cash on Hand|Company Cash Balance ADTX|GRI - Company Cash Funds|XRTX (XORTX Therapeutics Inc) - Company Cash and Cash Equivalents|HIND: Company Cash Volume|REVB (Revelation Bio) - Company Cash Funds|Company Cash Funds Indaptus|Scinai Immunotherapeutics (SCNI) - Company Liquid Assets|Company Cash Volume CALI|Company Cash on Hand Affimed NV AFMD|Company Cash Funds Allakos Inc ALLK|HOOK (HOOKIPA) - Company Total Cash Volume|IGM Biosciences - Company Cash Volume|ITOS - Company Cash Volume|Ocean Biomedical Corp (OCEA) - Company Cash Funds|TC BioPharm (Holdings) Plc - Company Cash Balance